(object) array( 'id' => '1461004', 'url' => 'SR/double-blind_study', 'image' => '', 'title' => 'duplo-slepa studija', 'tags' => array ( 0 => 'duplo-slepa studija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'duplo-slepa studija', 'source_id' => 30890, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Klinička studija u kojoj ni pojedinci koji u njoj učestvuju ni stručna lica koja studiju sprovode ne znaju koji ispitanici dobijaju eksperimentalni lek a koji placebo(ili drugu terapiju). Smatra se da duplo-slepa studija daje objektivne rezultate, pošto očekivanja lekara i ispitanika vezana za eksperimentalni lek ne utiču negativno na sam ishod:poznata još pod nazivom duplo-maskirana studija. Vidi slepa-studija,jednostruko-slepa studija i placebo', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907778, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'double-blind study', 'Definition' => 'A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study. See Blinded Study, Single-Blind Study, and Placebo.', 'Synonym' => 'double-masked study_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'double-blind_study', )

(object) array( 'id' => '1467639', 'url' => 'SR/randomization', 'image' => '', 'title' => 'randomizacija', 'tags' => array ( 0 => 'randomizacija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'randomizacija', 'source_id' => 30924, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709204516', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Metod zasnovan na slučajnosti kojom su ispitanici studije svrstani u određenu grupu za lečenje. Randomizaija smanjuje razliku između grupa time što jednako distribuira ljude sa odeređenim karakteristikama u sve grupe ispitivanja. Istraživači ne znaju koji način lečenja je bolji. Ono što je poznato je da svaki od načina lečenja može biti koristan za ispitanika.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999171936260, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'randomization', 'Definition' => 'A method based on chance by which study participants are assigned to a treatment group. Randomization minimizes the differences among groups by equally distributing people with particular characteristics among all the trial arms. The researchers do not know which treatment is better. From what is known at the time, any one of the treatments chosen could be of benefit to the participant.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'randomization', )

(object) array( 'id' => '1461047', 'url' => 'SR/phase_i_trials', 'image' => '', 'title' => 'Prva faza ispitivanja', 'tags' => array ( 0 => 'Prva faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Prva faza ispitivanja', 'source_id' => 30916, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Početne studije sa ciljem određivanja metabolizma i farmakološkog dejstva lekova na čoveka, neželjena dejstva vezana za povećane doze, kao i sticanja ranog uvida u efikasnost leka; može uključiti ispitanike bez zdravstvenih problema odnosno pacijente.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247810, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase i trials', 'Definition' => 'Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_i_trials', )

(object) array( 'id' => '1461313', 'url' => 'SR/virtual_HR', 'image' => '', 'title' => 'virtualni HR', 'tags' => array ( 0 => 'virtualni HR', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'virtualni HR', 'source_id' => 40113, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705224003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Obezbeđivanje HR usluga koristeći platforme samostalnog pružanja usluga zaposlenih.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862272, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'virtual HR', 'Definition' => 'Providing HR services through employee self-sevice platforms.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'virtual_HR', )

(object) array( 'id' => '1460609', 'url' => 'SR/confidentiality_regarding_trial_participants', 'image' => '', 'title' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'tags' => array ( 0 => 'poverljivost podataka učesnika u kliničkom ispitivanju', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'source_id' => 30883, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705083507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na poštovanje poverljivosti podataka učesnika u kliničkom ispitivanju uključujući njihov identitet i sve lične medicinskwe informacije. Odobrenje za korišćenje dobijenih podataka radi verifikacije samih podataka mora unapred biti dobijeno od učesnika ispitivanja kao i uverenje da poverljivost mora biti zagarantovana.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964695805952, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'confidentiality regarding trial participants', 'Definition' => 'Refers to maintaining the confidentiality of trial participants including their personal identity and all personal medical information. The trial participants\' consent to the use of records for data verification purposes should be obtained prior to the trial and assurance must be given that confidentiality will be maintained.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'confidentiality_regarding_trial_participants', )

(object) array( 'id' => '1461006', 'url' => 'SR/orphan_drugs', 'image' => '', 'title' => 'lekovi ,,siročići\'\'', 'tags' => array ( 0 => 'lekovi ,,siročići\'\'', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'lekovi ,,siročići\'\'', 'source_id' => 30914, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kategorija Administracije za hranu i lekove koja se odnosi na lekove koji se koriste u lečenju retkih bolesti i stanja. Slabo ima finansijske motivacije za farmaceutsku industriju u pogčedu razvoja lekova za ovakve bolesti i stanja. Status lekova ,,siročića\'\', u svakom slučaju daje proizvođaču posebnu finansijsku motivaciju za razvoj i obezbeđivanje takvih lekova.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907780, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'orphan drugs', 'Definition' => 'An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. Orphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'orphan_drugs', )

(object) array( 'id' => '1461054', 'url' => 'SR/recruitment_status', 'image' => '', 'title' => 'faza zapošljavanja novih kadrova', 'tags' => array ( 0 => 'faza zapošljavanja novih kadrova', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'faza zapošljavanja novih kadrova', 'source_id' => 30927, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705160003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na trentnu fazu ispitivanja, bilo da je planirana, već u proceduri ili završena. Moguće vrednosti podrazumvaju', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966610505730, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'recruitment status', 'Definition' => 'Indicates the current stage of a trial, whether it is planned, ongoing, or completed. Possible values include', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'recruitment_status', )

(object) array( 'id' => '1461310', 'url' => 'SR/personal_file_access_policy', 'image' => '', 'title' => 'Politika pristupa ličnim fajlovima', 'tags' => array ( 0 => 'Politika pristupa ličnim fajlovima', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Politika pristupa ličnim fajlovima', 'source_id' => 40104, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705223509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Politika koja dozvoljava sadašnjim i ranijim zaposlenima pristup svojim fajlovima, pod uslovom da unpared o tome obaveste menadžera za ljudske resurse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813699, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'personal file access policy', 'Definition' => 'A policy allowing current and prior employees access to their own files, provided they let HR know in advance.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'personal_file_access_policy', )

(object) array( 'id' => '1461311', 'url' => 'SR/Family_and_Medical_Leave_Act', 'image' => '', 'title' => 'Zakon o porodičnom i zdravstvenom odsustvu', 'tags' => array ( 0 => 'Zakon o porodičnom i zdravstvenom odsustvu', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Zakon o porodičnom i zdravstvenom odsustvu', 'source_id' => 40085, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705223510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Ovaj zakon nalaže da poslodavci moraju omogućiti najviše 12 nedelja neplaćenog odsustva kvalifikovanim zaposlenima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813700, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Family and Medical Leave Act', 'Definition' => 'This act stipulates that employers must provide up to 12 weeks of unpaid leave to eligible employees.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Family_and_Medical_Leave_Act', )

(object) array( 'id' => '1467655', 'url' => 'SR/Lamictal', 'image' => '', 'title' => 'Lamictal', 'tags' => array ( 0 => 'Lamictal', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamictal', 'source_id' => 31148, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210502', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju epilepsije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845761, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamictal', 'Definition' => 'a prescription drug used to treat epilepsy', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamictal', )